Clinical Trial: A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603856) titled 'A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer' on March 09.

Brief Summary: Current clinical trials testing the combination of immunotherapy with radiotherapy.

Study Start Date: Dec. 12, 2026

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer Metastatic Lung Cancer

Intervention: DRUG: Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab)

Participant will receive an FDA approved immunotherapy according to usual routine practice.

DRUG: Investigator Choice Chemotherapy (for example docetaxel with or with...